Sale!

CEBPA Mutation Detection Test Cost

Original price was: 1,870 د.إ.Current price is: 1,680 د.إ.

-10%

The CEBPA Mutation Detection Test is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at identifying mutations in the CEBPA gene. This gene plays a crucial role in regulating cell differentiation and proliferation, and its mutations are often linked to various types of blood disorders, including acute myeloid leukemia (AML). The test is particularly important for patients suspected of having blood-related malignancies, as it helps in the precise diagnosis and enables tailored treatment strategies based on the genetic profile.

Performed using advanced molecular techniques, the test requires a sample of the patient’s blood or bone marrow. The process meticulously scans the CEBPA gene for any abnormalities that could be indicative of a predisposition to or the presence of hematologic diseases.

At DNA Labs UAE, the CEBPA Mutation Detection Test is priced at 1680 AED. The cost reflects the sophisticated technology and expertise required to accurately detect and interpret gene mutations. For patients and healthcare providers, the test represents a crucial step towards personalized medicine, offering insights that can significantly impact treatment decisions and outcomes.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

CEBPA MUTATION DETECTION Test

Components: CEBPA MUTATION DETECTION Test

Price: 1680.0 AED

Sample Condition: 4 mL (2 mL min.) whole blood in 1 Lavender top (EDTA) tube. Ship refrigerated. DO NOT FREEZE.

Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory.

Report Delivery: Sample Daily by 11 am; Report 10 Working days

Method: PCR

Test type: Leukemia

Doctor: Oncologist

Test Department: MOLECULAR DIAGNOSTICS

Pre Test Information: Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory.

Test Details

The CEBPA mutation detection test is a diagnostic test used to identify mutations in the CEBPA gene. The CEBPA gene encodes for a transcription factor that plays a crucial role in the development and maturation of myeloid cells, which are a type of white blood cell.

Mutations in the CEBPA gene have been associated with various types of leukemia, particularly acute myeloid leukemia (AML). These mutations can affect the normal function of the CEBPA protein and disrupt the regulation of genes involved in cell growth and differentiation, leading to the development of cancer.

The CEBPA mutation detection test typically involves analyzing a sample of the patient’s blood or bone marrow for specific mutations in the CEBPA gene. This can be done using various techniques, such as polymerase chain reaction (PCR) or DNA sequencing.

Identifying CEBPA mutations can be important for guiding treatment decisions in patients with AML. Certain CEBPA mutations are associated with better outcomes and may influence the choice of therapy, such as the use of targeted therapies or stem cell transplantation.

Overall, the CEBPA mutation detection test is a valuable tool in the diagnosis and management of AML and other leukemias associated with CEBPA gene mutations. It helps to provide personalized treatment options and improve patient outcomes.

Test Name CEBPA MUTATION DETECTION Test
Components
Price 1680.0 AED
Sample Condition 4 mL (2 mL min.) whole blood in 1 Lavender top (EDTA) tube. Ship refrigerated. DO NOT FREEZE. Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory.
Report Delivery Sample Daily by11 am;Report 10 Working days
Method PCR
Test type Leukemia
Doctor Oncologist
Test Department: MOLECULAR DIAGNOSTICS
Pre Test Information Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory.
Test Details

The CEBPA mutation detection test is a diagnostic test used to identify mutations in the CEBPA gene. The CEBPA gene encodes for a transcription factor that plays a crucial role in the development and maturation of myeloid cells, which are a type of white blood cell.

Mutations in the CEBPA gene have been associated with various types of leukemia, particularly acute myeloid leukemia (AML). These mutations can affect the normal function of the CEBPA protein and disrupt the regulation of genes involved in cell growth and differentiation, leading to the development of cancer.

The CEBPA mutation detection test typically involves analyzing a sample of the patient’s blood or bone marrow for specific mutations in the CEBPA gene. This can be done using various techniques, such as polymerase chain reaction (PCR) or DNA sequencing.

Identifying CEBPA mutations can be important for guiding treatment decisions in patients with AML. Certain CEBPA mutations are associated with better outcomes and may influence the choice of therapy, such as the use of targeted therapies or stem cell transplantation.

Overall, the CEBPA mutation detection test is a valuable tool in the diagnosis and management of AML and other leukemias associated with CEBPA gene mutations. It helps to provide personalized treatment options and improve patient outcomes.